1. Home
  2. UIS vs MDXH Comparison

UIS vs MDXH Comparison

Compare UIS & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unisys Corporation New

UIS

Unisys Corporation New

HOLD

Current Price

$2.28

Market Cap

205.4M

Sector

Technology

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$3.29

Market Cap

183.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
UIS
MDXH
Founded
1942
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
205.4M
183.4M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
UIS
MDXH
Price
$2.28
$3.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$5.67
$7.67
AVG Volume (30 Days)
897.1K
103.1K
Earning Date
05-26-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,950,100,000.00
N/A
Revenue This Year
N/A
$30.31
Revenue Next Year
$2.60
$18.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.11
$1.36
52 Week High
$5.33
$5.33

Technical Indicators

Market Signals
Indicator
UIS
MDXH
Relative Strength Index (RSI) 44.14 45.06
Support Level $2.11 $3.05
Resistance Level $2.65 $3.78
Average True Range (ATR) 0.12 0.15
MACD 0.01 -0.01
Stochastic Oscillator 17.86 22.73

Price Performance

Historical Comparison
UIS
MDXH

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. Majority of revenue is from ECS segment.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: